John Shumaker - Paragon 28 Executive US

FNADelisted Stock  USD 13.09  0.00  0.00%   

Executive

John Shumaker is Executive US of Paragon 28
Phone720-912-1332
Webhttps://paragon28.com

Paragon 28 Management Efficiency

The company has Return on Asset of (0.0818) % which means that on every $100 spent on assets, it lost $0.0818. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3639) %, meaning that it generated no profit with money invested by stockholders. Paragon 28's management efficiency ratios could be used to measure how well Paragon 28 manages its routine affairs as well as how well it operates its assets and liabilities.
Paragon 28 has 640 K in debt with debt to equity (D/E) ratio of 0.24, which may show that the company is not taking advantage of profits from borrowing. Paragon 28 has a current ratio of 3.59, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Paragon to invest in growth at high rates of return.

Similar Executives

Showing other executives

EXECUTIVE Age

Julie AndrewsOrthofix Medical
54
Jeff ChiprinIradimed Co
59
Justin WardBruker
N/A
Jennifer EnglundCVRx Inc
N/A
John HarrisInteger Holdings Corp
65
Randy WaddellIradimed Co
N/A
Dan YarbroughOrthofix Medical
N/A
Chris CalcaterraGlaukos Corp
65
Tonya SPHRCVRx Inc
53
Steve KachelmeyerIradimed Co
N/A
MD FACSGlaukos Corp
N/A
Thomas BuresBruker
50
Brent JDBruker
50
Suzanne ArmstrongOrthofix Medical
N/A
Kimberly LockwoodCONMED
N/A
Chris WilliamsonIradimed Co
N/A
Christopher LewisGlaukos Corp
N/A
Lynn NeuhardtIradimed Co
N/A
Daniel EsqCONMED
60
Katie KellerNeuropace
N/A
RN MBACVRx Inc
N/A
Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado. Paragon 28 operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 343 people. Paragon 28 (FNA) is traded on New York Stock Exchange in USA and employs 525 people.

Management Performance

Paragon 28 Leadership Team

Elected by the shareholders, the Paragon 28's board of directors comprises two types of representatives: Paragon 28 inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Paragon. The board's role is to monitor Paragon 28's management team and ensure that shareholders' interests are well served. Paragon 28's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Paragon 28's outside directors are responsible for providing unbiased perspectives on the board's policies.
Matthew Jarboe, Executive Officer
Albert DaCosta, President, Chief Executive Officer, Co-Founder
B Johnson, Director
Kristina Wright, Independent Director
Matthew Brinckman, Senior Relations
Sanket JD, Deputy VP
Matt Jarboe, Chief Commercial Officer
Matt Brinckman, Senior Relations
Yuliya Aslan, Senior IT
Chadi Chahine, CFO Operations
Matthew Millard, Chief Officer
Frank Bono, Co-Founder, Chief Technology Officer
Jim Riegler, Co-Founder, Chief Financial Officer
Jeff Sears, Vice Operations
Erik Mickelson, Chief Controller
Krissy Wright, Director
Michelle Missal, VP Officer
Brendan Shook, Executive Vice President - Marketing and Medical Education
Stephen Deitsch, Chief Officer
Steve Deitsch, Principal Financial Officer
Francis Bono, Co-Founder, Chief Technology Officer
John Shumaker, Executive US
Hans Kestler, Executive International
Lee Rosenthal, Co-Founder, Vice President - National Accounts
Andrew Hill, Executive Development
Jonathan Friedman, General Secretary
Jason Edie, Chief Officer
Robert JD, General Secretary
Meghan Scanlon, Director

Paragon Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Paragon 28 a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Paragon Stock

If you are still planning to invest in Paragon 28 check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Paragon 28's history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world